Foley Partner Jacqueline Wright Bonilla appeared in a video segment published to BioCentury This Week on November 14, 2010 titled “Myriad Pro-Con.” Wright Bonilla clarifies the definition of gene patents and makes the case for a company’s right to commercialize research and development that could lead to a diagnostic in a drug. She also discusses the Assn. for Molecular Pathology, et al. v. USPTO, et al. (ACLU v. Myriad) “gene patenting” case.
Related News
13 February 2025
In the News
Nikhil Pradhan on FDA Draft AI Drug Guidance – 'The industry is very much evolving'
Foley & Lardner LLP senior counsel Nikhil Pradhan shared insight on recent draft guidance from the U.S. Food and Drug Administration's in the MedCentral article, "FDA Draft Guidance Addresses Drug Submissions that Use AI Data."
12 February 2025
In the News
Carrie Hoffman Quoted on Federal Arbitration Act's Transportation Exemption
11 February 2025
In the News
Foley Attorneys on CFPB Shutdown – Industry in 'wait-and-see mode'
Foley & Lardner LLP attorneys Christi Lawson, Natasha Dempsey, and Whitney Nicholas assessed the Trump administration's curtailment of the Consumer Financial Protection Bureau (CFPB) in the Newsweek article, "What CFPB Shutdown Means for Junk Fees."